The Blood and Marrow Transplant (BMT) Program at Northside Hospital (NH) is one of the largest and most comprehensive programs of its kind in the Southeast. Northside Hospital’s BMT Program is committed to providing clinical excellence and compassionate care for patients undergoing bone marrow and stem cell transplantation.
In 2025, Northside Hospital had among the best allogeneic transplant survival outcomes in the United States for the 17th consecutive year (2009-25), per data released by NMDP and the Center for International Blood and Marrow Transplant Research 1. Northside Hospital was also the only center in the country (out of 176) in 2025 to maintain outcomes in the “above expected” range for 17 consecutive reporting years.
For more information, or to refer a patient to the Blood and Marrow Transplant Program at Northside Hospital Cancer Institute, please call 404-255-1930.
Bone marrow is the soft, spongy tissue inside the bones. Normal bone marrow has special cells called stem cells. These stem cells grow and change into different types of blood cells, including red blood cells, white blood cells, and platelets. When they are fully grown, they leave the bone marrow and go into the bloodstream.
When they are fully grown, they leave the bone marrow and go into the bloodstream.
A bone marrow transplant is a procedure to replace unhealthy bone marrow with healthy stem cells.
Doctors do a bone marrow transplant when a person’s bone marrow is not working properly or has been damaged by disease or strong treatments like chemotherapy. This can happen in illnesses such as cancer or blood disorders. The new stem cells help the body make healthy blood cells again.
NHCI performs the following types of blood and bone marrow transplants:
The Blood and Marrow Transplant Program at Northside Hospital Cancer Institute is the largest allogeneic program in Georgia and is the only program in the country to exceed expected survival rates for allogeneic transplants for 17 years in a row.
The BMT Program at Northside Hospital Cancer Institute treats the following types of hematologic disorders:
The BMT Program is a collaboration between the Blood & Marrow Transplant Group of Georgia (BMTGA) and Northside Hospital and is one of the largest clinical transplant programs in the United States, serving patients who are undergoing bone marrow/stem cell transplant therapy and providing primary leukemia treatment.
Our Program is nationally recognized or accredited by the following organizations:
Northside’s BMT physicians have completed hematopoietic stem cell transplant fellowship training at prestigious universities such as Johns Hopkins School of Medicine; University of California at San Diego; National Institutes of Health; National Heart, Lung and Blood Institute; the University of Minnesota, the Ohio State University, and Oregon Health & Science University. In addition to providing leadership to the BMT Program at Northside Hospital, these physicians manage the clinical care of patients in the hospital and outpatient settings.
Northside Hospital’s BMT physicians are on call 24 hours a day, seven days a week. For more information or to refer a patient to the Blood and Marrow Transplant Program at Northside Hospital Cancer Institute, please call 404-255-1930.
Northside Hospital Cancer Institute offers state-of-the-art inpatient and outpatient BMT facilities at the Northside Hospital campus in Atlanta. Our nursing and mid-level practitioners undergo extensive annual training to ensure the highest level of care is achieved for all BMT patients being treated at Northside.
Expand the content below to learn more about our program facilities.
Research is a major component of the BMT Program at Northside Hospital Cancer Institute. Our clinical research team includes research nurses, quality assurance research coordinator, pharmacists experienced in the handling of investigational agents, and laboratory personnel. Physicians and the research team will discuss the best treatment options available to patients, including standard of care treatment and/or participation in a clinical trial. The BMT Program has access to clinical trials through the National Cancer Institute, Blood & Marrow Transplant Clinical Trials Network (BMTCTN) and pharmaceutical sponsors.
For more information, or to refer a patient to the Blood and Marrow Transplant Program at Northside Hospital Cancer Institute, please call 404-255-1930.
For any patient facing a blood and marrow transplant recovery, having ongoing comprehensive and compassionate cancer support is crucial. Northside Hospital Cancer Institute’s BMT Program provides a full range of support and survivorship programs and services to address the unique needs of each transplant, leukemia and immunotherapy patient.
Blood and marrow transplant treatment and recovery can be long and overwhelming, which is why the Northside’s BMT program offers patients and their families services especially designed to support them throughout their entire journey.
DISCLAIMER
1 2025 Transplant Center Specific Survival Report, December 2025. This survival information includes only patients who received their first allogeneic transplant between January 1, 2021 and December 31, 2023, using unrelated or related donors and who had reported follow-up. Specific transplant center information can be found at nmdp.org.
